Literature DB >> 1353368

Comparison of bisoprolol and diazepam in the treatment of cardiac neurosis.

R Fogari1, A Zoppi, L Corradi, C Pasotti, G D Malamani, R Gradnik, D Bokor, C Gala.   

Abstract

In order to compare the beta blockers bisoprolol and diazepam in the treatment of cardiac neurosis, 40 patients (16 males and 24 females, mean age: 39 +/- 11 years) were examined in a double-blind, crossover study. Following a 4-week placebo period, patients were randomized to receive either bisoprolol 10 mg daily or diazepam 5 mg twice daily for 4 weeks. After a second 4-week washout period on placebo, patients were switched to the alternative regimen for a further 4 weeks. At the end of the placebo periods and during each phase of treatment, the following parameters were evaluated: somatic symptoms by self-assessment questionnaire, anxiety state by Hamilton rating scale, reaction time to both acoustic and visual stimuli, blood pressure, and heart rate. Both treatments were effective in reducing somatic symptoms of cardiac neurosis, but bisoprolol was significantly more effective than diazepam (p less than 0.01). On the contrary, diazepam was superior to bisoprolol in improving the Hamilton scale related to psychic symptoms. Only diazepam prolonged reaction times. Both treatments were well tolerated; however, 12 patients complained of drowsiness and nine of sedation under diazepam. In conclusion, bisoprolol appeared to be as effective as diazepam in the treatment of cardiac neurosis, but with better effects on somatic symptoms and without affecting patients' psychomotor performance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353368     DOI: 10.1007/bf00051146

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  29 in total

1.  [Treatment of neurocirculatory asthenia].

Authors:  G Patron; C Duperier; M Degeorges
Journal:  Rev Prat       Date:  1976-01-21

Review 2.  THE PSYCHOPHYSIOLOGY OF ANXIETY; WITH A REVIEW OF THE LITERATURE CONCERNING ADRENALINE.

Authors:  P R BREGGIN
Journal:  J Nerv Ment Dis       Date:  1964-12       Impact factor: 2.254

3.  The idiopathic high cardiac output state.

Authors:  R GORLIN; N BRACHFELD; J D TURNER; J V MESSER; E SALAZAR
Journal:  J Clin Invest       Date:  1959-12       Impact factor: 14.808

4.  Propranolol in the treatment of neurocirculatory asthenia--an open pilot study.

Authors:  R Rimón; R Kampman; M Viukari
Journal:  Isr Ann Psychiatr Relat Discip       Date:  1979-06

5.  Use of beta-blocking drugs in psychiatry and neurology.

Authors:  P J Tyrer
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

6.  Randomized comparison of atenolol and placebo in the treatment of anxiety: a double-blind study.

Authors:  P Saul; B P Jones; K G Edwards; J A Tweed
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Physiological and psychological effects of ±-propranolol, +-propranolol and diazepam in induced anxiety.

Authors:  P J Tyrer; M H Lader
Journal:  Br J Clin Pharmacol       Date:  1974-10       Impact factor: 4.335

8.  Long-term treatment of hyperkinetic heart syndrome with propranolol.

Authors:  M Guazzi; A Polese; F Magrini; C Fiorentini; M T Olivari
Journal:  Am J Med Sci       Date:  1975 Nov-Dec       Impact factor: 2.378

9.  Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.

Authors:  G Leopold; W Ungethüm; J Pabst; Z Simane; K U Bühring; H Wiemann
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

10.  Central and peripheral effects of propranolol and sotalol in normal human subjects.

Authors:  M H Lader; P J Tyrer
Journal:  Br J Pharmacol       Date:  1972-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.